Achievement of objectives in adult patients with type 1 diabetes mellitus: estimated glucose disposition rate as a clinical marker

Authors

  • Alejandra Cicchitti Faculty of Medical Sciences, University Hospital, National University of Cuyo, Mendoza, Argentina
  • Edgardo Trinajstic Faculty of Medical Sciences, University Hospital, National University of Cuyo, Mendoza, Argentina
  • Joaquín González Faculty of Medical Sciences, University Hospital, National University of Cuyo, Mendoza, Argentina
  • Celina Bertona Faculty of Medical Sciences, University Hospital, National University of Cuyo, Mendoza, Argentina
  • Luis Lombardo Guaymallén Health Area, Ministry of Health, Mendoza, Argentina
  • Martín Rodríguez Faculty of Medical Sciences, University Hospital, National University of Cuyo, Mendoza, Argentina

DOI:

https://doi.org/10.47196/diab.v56i3.527

Keywords:

type 1 diabetes mellitus, therapeutic targets, c-LDL, HbA1c, smoking, physical activity, blood pressure, estimated glucose disposition rate

Abstract

Introduction: the clinical practice guidelines in diabetes mellitus (DM) establish precise clinical objectives for the good management of the disease, but little is known about adequate compliance in our environment. Being overweight and sedentary have generated stigmas of metabolic syndrome in the population with DM1.

Objectives: to evaluate the compliance with 5 of these criteria: HbA1c <7%, c-LDL ≤100 mg/dL, physical activity (PA) ≥3 times/week, systolic blood preasure (SBP) <140 mm Hg, and no smoking and its association with insulin resistance determined by the estimated glucose disposition rate (eGDR).

Material and methods: in 415 DM1 ≥18 years, 52% women, age 34.8±13.9 years, HbA1c, c-LDL, weekly frequency of structured PA, SBP, and current smoking were evaluated. The degree of association with gender, age, age of DM, level of education, medical coverage, BMI, and insulin sensitivity measured through eGDR was determined. Qualitative variables were analyzed by chi-square test and quantitative variables by ANOVA I test and analysis post hoc by Tukey's test for multiple comparisons. A value of p<0.05 was considered statistically significant. A 95% confidence interval was used in all cases.

Results: systolic BP <140 mm Hg presented 94.8%, current non-smoking 82.2%, c-LDL ≤ 100 mg/dL 56.5%, physical activity (PA) ≥3 times a week 39% and HbA1c <7% 20.3%. Only 26 patients (6.2%) achieved the 5 objectives analyzed in combination. The fulfillment of the 5 objectives was associated at the level of ≥ secondary education (p=0.002) and health coverage with social welfare or prepaid (p=0.002). There was a significant association between TeDG in those who fulfilled the 5 objectives (p=0.02) and individually in 4 of them (SPB, c-LDL, HbA1c, and PA).

Conclusions: of the 415 patients evaluated in our study, only 6.2% met the 5 criteria under consideration. Only control of SBP, non-smoking and c-LDL <100 were complied with by the majority of the patients. HbA1c <7% was the individual objective with the lowest degree of compliance.

Author Biographies

Alejandra Cicchitti, Faculty of Medical Sciences, University Hospital, National University of Cuyo, Mendoza, Argentina

Professor, Faculty of Medical Sciences; Staff Physician, University Hospital, National University of Cuyo

Edgardo Trinajstic, Faculty of Medical Sciences, University Hospital, National University of Cuyo, Mendoza, Argentina

Professor, Faculty of Medical Sciences, Staff Physician, University Hospital, National University of Cuyo

Joaquín González, Faculty of Medical Sciences, University Hospital, National University of Cuyo, Mendoza, Argentina

Professor, Faculty of Medical Sciences; Staff Physician, University Hospital, National University of Cuyo

Celina Bertona, Faculty of Medical Sciences, University Hospital, National University of Cuyo, Mendoza, Argentina

Professor, Faculty of Medical Sciences; Staff Physician, University Hospital, National University of Cuyo

Luis Lombardo, Guaymallén Health Area, Ministry of Health, Mendoza, Argentina

Staff Physician

Martín Rodríguez, Faculty of Medical Sciences, University Hospital, National University of Cuyo, Mendoza, Argentina

Professor, Faculty of Medical Sciences; Staff Physician, University Hospital, National University of Cuyo

References

I. De Ferranti S, de Boer IH, Fonseca V, Fox C, Golden S, et al. Type 1 diabetes mellitus and cardiovascular disease. A scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care 2014;37:2843-2863.

II. Ahlén E, Pivodic A, Wedel H, et al. Glycemic control, renal complications, and current smoking in relation to excess risk of mortality in persons with type 1 diabetes. Journal of Diabetes Science and Technology 2016;10:1006-1014.

III. American Diabetes Association. Diabetes Care 2020; 43 (Suppl.1):S1-S212.

IV. Foster N, Beck R, Miller K, Clements M, Rickels M, et al. State of type 1 diabetes management and outcomes from the T1D Exchange in 2016-2018. Diabetes Technol Ther 2019;21:66-72.

V. Aschner P, Gagliardino JJ, Ilkova H, et al. Non achievement of glycemic target. Results from the International Diabetes Management Practices Study (IDMPS). Poster 1030 ADA Meeting, Orlando, FL, 2018.

VI. Shah V, Wu M, Polsky S, Snell-Bergeon J, Sherr J, et al. Gender differences in diabetes self-care in adults with type 1 diabetes. Findings from the T1D Exchange clinic registry. Journal of Diabetes and Its Complications 2018;32:961-965.

VII. Gagliardino JJ, Aschner, Ilkova H, et al. Frequency of high blood pressure and dyslipidemia in T1D and T2D. Results from the International Diabetes Management Practices (IDMPS). Poster 621. ADA Meeting, Orlando FL, 2018.

VIII. Bohn B, Herbst A, Pfeifer M, Krakow D, Zimny S, et al; for the DPV Initiative. Impact of physical activity on glycemic control and prevalence of cardiovascular risk factors in adults with type 1 diabetes. A cross-sectional multicenter study of 18,028 patients. Diabetes Care 2015;38:1536-1543.

IX. Sliwinska-Mosson M, Milnerowicz H. The impact of smoking on the development of diabetes and its complications. Diab Vasc Dis Res 2017;14:265-276.

X. Rawshani A, Rawshani A, Franzén S, et al. Range of risk factor levels/control, mortality and cardiovascular outcomes in type 1 diabetes. Circulation 2017;135:1522-1531.

XI. Fazio L, Rodríguez M, Trinajstic E, et al. Estudio DIACONTA. Rev Arg Diab 2002; 88-89, póster 57.

XII. Teupe B, Bergis K. Epidemiological evidence for “double diabetes”. Lancet 1991; 337:361-362.

XIII. Kietsiriroje N, Sam Pearson S, Matthew Campbell M, Ariëns R, Ajjan R. Double diabetes: a distinct high-risk group? Diabetes Obes Metab 2019 Dec;21(12):2609-2618. doi: 10.1111/dom.13848

XIV. Cicchitti A, Bertona C, González J, Carrasco N, Barrera L, David R, Romero L, Biliato L, Trinajstic E, Rodríguez M; en representación del Grupo de Estudio MENDODIAB-1. Sobrepeso y obesidad en adultos con diabetes mellitus tipo 1. Rev Arg Diab 2019; 53:110-117.

XV. Cleland SJ, Fisher BM, Colhoun HM, Sattar N, Petrie JR. Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks? Diabetologia 2013; 56:1462-1470.

XVI. Cleland SJ. Cardiovascular risk in double diabetes mellitus. When two worlds collide. Nat Rev Endocrinol 2012;8:476-485.

XVII. Quinn LM, Wong FS, Narendran P. Environmental determinants of type 1 diabetes: from association to proving causality. Front Immunol 2021 Oct 1;12:737964. doi: 10.3389/fimmu.2021.737964.

XVIII. Merger SR, Kerner W, Stadler M, Zeyfang A, Jehle P, Müller-Korbsch M, Holl RW. Prevalence and comorbidities of double diabetes. Diabetes Research and Clinical Practice 2016;119:48-56.

XIX. Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 2000;49:626-632.

XX. Tercera Encuesta Nacional de Factores de Riesgo para Enfermedades No Transmisibles. 10 de Julio de 2015. Buenos Aires, Argentina. ISBN: 978-950-38-0218-2. Disponible en: https://bancos.salud.gob.ar/sites/default/files/2018-10/0000000544cnt-2015_09_04_encuesta_nacional_factores_riesgo.pdf.

XXI. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008;358:580-91.

XXII. Dorman J, Laporte R, Kuller L, et al. The Pittsburgh Insulin-dependent Diabetes MelIitus (IDDM) morbidity and mortality study. Diabetes 1984;33:271-276.

XXIII. Rawshani A, Rawshani A, Franzén S, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med 2017;376:1407-18.

XXIV. Rawshani A, Sattar N, Franzén S, et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet 2018; 392:477-86.

XXV. Instituto Nacional de Estadística y Censos (INDEC). Cuarta Encuesta Nacional de Factores de Riesgo. Resultados definitivos. 1º Ed. Ciudad Autónoma de Buenos Aires Secretaría de Gobierno de Salud de la Nación, 2019. ISBN 978-950-896-554-7. Disponible en: https://www.indec.gob.ar/ftp/cuadros/publicaciones/enfr_2018_resultados_definitivos.pdf.

XXVI. McCarthy MM, Funk M, Grey M. Cardiovascular health in adults with type 1 diabetes. Prev Med 2016;91:138-143.

XXVII. González J, Bertona C, Cicchitti A, Previtera V, Calella P, Ávila P, Rodríguez-Papini N, Acosta S, Trinajstic E, Rodríguez M; en representación del Grupo de Estudio MENDODIAB-1. Tabaquismo en adultos con DM1. Rev Arg Diab 2018; XXI Congreso Argentino de Diabetes, poster 61.

XXVIII. Lyons S, Boyle C, DeSalvo D, Rickels M, Wood Heickman L, Miller K. Dyslipidaemia and statin use in individuals aged 10 to <40 years in the T1D Exchange clinic registry. Diabetes Obes Metal 2019;21(1):170-172. doi:10.1111/dom.13475.

XXIX. American Diabetes Association. Standards of Medical Care in Diabetes 2020. Diabetes Care January 2020;Vol 43, Supp 1.

XXX. Abed E, LaBarbera B, Dvorak J, Zhang Y, Beck J, Talsania M. Prevalence of dyslipidemia and factors affecting dyslipidemia in young adults with type 1 diabetes: evaluation of statin prescribing. J Pediatr Endocrinol Metab 2019; 32(4):327-334. doi:10.1515/jpem-2018-0383.

XXXI. Cicchitti A, Bertona C, González J, Bellomo F, Bidot L, Mengoni K, Giorgini D, Abdala L, Negri G, Trinajstic E, Rodríguez M. Actividad física y control glucémico, complicaciones agudas, complicaciones microvasculares, y factores de riesgo cardiovascular en adultos con diabetes tipo 1. Rev ALAD 2019,9:111-7.

XXXII. Nyström T, Holzman M, Eliasson B, Svensson A, Sartipy, U. Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes. Diabetes Obes Metab 2018;20:556-563.

XXXIII. Epstein E, Osman J, Cohen H, et al. Use of the estimated glucose disposal rate as a measure of insulin resistance in an urban multiethnic population with type 1 diabetes. Diabetes Care 2013;36:2280-2285.

XXXIV. Olson J, Erbey J, Williams K, et al. Subclinical atherosclerosis and estimated glucose disposal rate as predictors of mortality in type 1 diabetes. Ann Epidemiol 2002;12:331-3.

XXXV. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.

XXXVI. Organización Mundial de la Salud. Informe Argentina 2017. Disponible en: http://administracionsalud.com.ar/organizacion-mundial-de-la-salud-informe-argentina-2017.

Downloads

Published

2022-12-01

How to Cite

Cicchitti, A., Trinajstic, E., González, J., Bertona, C., Lombardo, L., & Rodríguez, M. (2022). Achievement of objectives in adult patients with type 1 diabetes mellitus: estimated glucose disposition rate as a clinical marker. Journal of the Argentine Society of Diabetes, 56(3), 93–100. https://doi.org/10.47196/diab.v56i3.527

Issue

Vol. 56 No. 3 (2022): September/December 2022

Section

Original article

License

Copyright (c) 2022 in the name of the authors. Reproduction rights: Argentine Diabetes Society.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.

La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.

Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.

 

Most read articles by the same author(s)

1 2 3 > >>